Chromocell Therapeutics (CHRO) Stock Chart & Stock Price History $1.84 +0.59 (+46.61%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.88 +0.04 (+2.45%) As of 04/17/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Chromocell Therapeutics Stock Price Performance 5 Day Performance+41.54%1 Month Performance+25.17%3 Month Performance-3.16%6 Month Performance+164.56%Year-To-Date Performance+187.05%1 Year Performance+19.48% Receive CHRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CHRO Stock Chart for Sunday, April, 20, 2025 CHRO Chart by TradingView Chromocell Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$1.84$1.84$2.37$1.6939.40 million shs$11.23 million04/17/2025$1.26$1.84+46.61%$2.37$1.6939.40 million shs$11.23 million04/16/2025$1.30$1.26-3.46%$1.26$1.221,146 shs$7.66 million04/15/2025$1.35$1.30-3.70%$1.31$1.213,393 shs$7.94 million04/14/2025$1.30$1.35+4.25%$1.37$1.291,974 shs$8.24 million04/11/2025$1.35$1.30-4.07%$1.35$1.251,994 shs$7.91 million04/10/2025$1.35$1.35+0.37%$1.35$1.263,007 shs$8.24 million04/09/2025$1.37$1.35-1.75%$1.39$1.302,920 shs$8.21 million04/09/2025$1.37$1.35-1.75%$1.39$1.302,920 shs$8.21 million04/08/2025$1.33$1.37+2.93%$1.41$1.319,376 shs$8.36 million Get the Latest News and Ratings for CHRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$1.33$1.37+2.93%$1.41$1.319,376 shs$8.36 million04/07/2025$1.33$1.33$1.40$1.304,879 shs$8.12 million04/04/2025$1.37$1.33-2.56%$1.36$1.331,997 shs$8.02 million04/03/2025$1.45$1.37-5.82%$1.41$1.341,437 shs$8.23 million04/02/2025$1.35$1.45+7.76%$1.57$1.336,563 shs$8.74 million04/01/2025$1.40$1.35-3.72%$1.35$1.341,914 shs$8.11 million03/31/2025$1.59$1.40-12.14%$1.61$1.369,294 shs$8.42 million03/28/2025$1.48$1.59+7.43%$2.00$1.5724,822 shs$9.59 million03/27/2025$1.45$1.48+1.86%$1.70$1.455,868 shs$8.92 million03/26/2025$1.50$1.45-3.13%$1.64$1.443,591 shs$8.76 million03/25/2025$1.48$1.50+1.35%$1.53$1.454,007 shs$9.04 million03/24/2025$1.57$1.48-5.73%$1.52$1.455,297 shs$8.92 million03/21/2025$1.47$1.57+6.80%$1.57$1.455,121 shs$9.46 million03/20/2025$1.59$1.47-7.55%$1.59$1.473,276 shs$8.86 million03/19/2025$1.58$1.59+0.63%$1.70$1.459,336 shs$9.59 million Related Companies Werewolf Therapeutics Stock Chart Estrella Immunopharma Stock Chart Coeptis Therapeutics Stock Chart Kezar Life Sciences Stock Chart Reviva Pharmaceuticals Stock Chart Marinus Pharmaceuticals Stock Chart FibroGen Stock Chart MiNK Therapeutics Stock Chart Akari Therapeutics Stock Chart Surrozen Stock Chart Receive CHRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CHRO) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chromocell Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chromocell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
